Nanomedicine: Magnetic nanoparticles for drug delivery and hyperthermia - New chances for cancer therapy;Pharmakotherapie mittels nanomedizin: Magnetische nanopartikel für drug delivery und hyperthermie - Neue chancen für die krebsbehandlung

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 53, Issue 8, 2010, Pages 839-845

  Alexiou, C ^a   Tietze, R ^a   Schreiber, E ^a   Lyer, S ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Drug delivery; Hyperthermia; Magnetic drug targeting; Nanomedicine; Nanoparticles

Indexed keywords

ANTINEOPLASTIC AGENT; FERRIC ION; FERRIC OXIDE; NANOPARTICLE;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; HUMAN; HYPERTHERMIC THERAPY; METHODOLOGY; NANOMEDICINE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALIZED MEDICINE;

ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; HUMANS; HYPERTHERMIA, INDUCED; INDIVIDUALIZED MEDICINE; MAGNETIC RESONANCE IMAGING; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956109571     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-010-1097-9     Document Type: Article

References (50)

1. WHO (2007) Cancer. Vol 2010. http://www.who.int/mediacentre/factsheet/ fs297/en/index.html
2. Krebsgesellschaft D (2008) Krebs in Deutschland. Häufigkeiten und Trends. Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. in Zusammenarbeit mit dem Robert Koch-Institut, Berlin. http://www. krebsgesellschaft.de/download/Kid2008/.pdf
3. Wagner V, Dullaart A, Bock AK et al (2006) The emerging nanomedicine landscape. Nat Biotechnol 24:1211-1217
4. Peer D, Karp JM, Hong S et al (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751-760
5. Perkins WR, Ahmad I, Li XG et al (2000) Novel therapeutic nano-particles (lipocores): trapping poorly water soluble compounds. Int J Pharm 27-39
6. Pankhurst QA, Thanh NKT, Jones SK et al (2009) Progress in applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 42:224001-224016
7. Bilkenroth U, Taubert H, Riemann D et al (2001) Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation. Int J Cancer 92:577-582
8. Taupitz M, Wagner S, Hamm B et al (1993) MR lymphography using iron oxide particles. Detection of lymph node metastases in the VX2 rabbit tumour model. Acta Radiol 34:10-15
9. Harisinghani MG, Barentsz J, Hahn PF et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491-2499
10. Gao Y, Kumar C (Hrsg) (2005) Biofunctionalization of nanomaterials, vol 72. Wiley-VCH GmbH & Co. KGaA, Weinheim
11. Storm G, Belliot SO, Daemen T et al (1995) Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliver Rev 17:31-48
12. Muller RH, Jacobs C, Kayser O (2001) Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliver Rev 47:3-19
13. Alksne JFFA, Rand R (1966) Magnetically controlled metallic thrombosis of intracranial aneurysms. Surgery 60:212-218
14. Widder KJ, Morris RM, Howard DP et al (1993) Selective targeting of magnetic albumin microspheres to the yoshida sarcoma: ultrastructural evalutation of microsphere distribution. Eur J Cancer Clin Oncol 19:141-147
15. Wilson MW, Kerlan RK Jr, Fidelman NA et al (2004) Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/conventional angiography suite - initial experience with four patients. Radiology 230:287-293
16. Lubbe AS, Bergemann C, Riess H et al (1996) Clinical experiences with magnetic drag targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 56:4686-4693
17. Alexiou C, Jurgons R, Schmid RJ et al (2003) Magnetic drug targeting - biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target 11:139-149
18. Brigger I, Morizet J, Laudani L et al (2004) Negative preclinical results with stealth ((R)) nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model. J Control Release 100:29-40
19. Alexiou C, Diehl D, Henninger P et al (2006) A high field gradient magnet for magnetic drug targeting. IEEE Trans Appl Supercond 16:1527-1530
20. Alexiou C, Jurgons R, Schmid R et al (2005) Magnetic drug targeting - a new approach in locoregional tumortherapy with chemotherapeutic agents. Experimental animal studies. HNO 53:618-622
21. Alexiou C, Arnold W, Hulin P et al (2001) Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting. J Magn Magn Mater 225:187-193
22. Rahn H, Gomez-Morilla I, Jurgons R et al (2008) Microcomputed tomography analysis of ferrofluids used for cancer treatment. J Phys Condens Matter 20:204152-204156
23. Alexiou C, Hulin P, Klein RJ et al (2002) Magnetic drug targeting: biodistribution and dependency on magnetic field strength. J Magn Magn Mater 252:363-366
24. Alexiou C, Arnold W, Klein RJ et al (2000) Locoregional cancer treatment with magnetic drug targeting. Cancer Res 60:6641-6648
25. Alexiou C, Schmid RJ, Jurgons R et al (2006) Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur Biophysics J Biophysics Letters 35:446-450
26. Nauts HCF, Bogatko FH (1953) A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study. Acta Med Scand 276:1-103
27. Gilchrist RK, Medal R, Shorey WD et al (1957) Selective inductive heating of lymph nodes. Ann Surg 146:596-606
28. Gordon RT, Hines JR, Gordon D (1979) Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Med Hypotheses 5:83-102
29. Jordan A, Scholz R, Wust P et al (1997) Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int J Hyperthermia 13:587-605
30. Johannsen M, Thiesen B, Jordan A et al (2005) Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate 64:283-292
31. Hilger I, Andra W, Hergt R et al (2001) Electromagnetic heating of breast tumors in interventional radiology: in vitro and in vivo studies in human cadavers and mice. Radiology 218:570-575
32. Moskovitz B, Meyer G, Kravtzov A et al (2005) Thermo-chemotherapy for intermediate or high-risk recurrent superficial bladder cancer patients. Ann Oncol 16:585-589
33. Iijima S (1991) Helical microtubules of graphitic carbon. Nature 354:56-58
34. Kostarelos K, Bianco A, Prato M (2009) Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol 4:627-633
35. Pankhurst QA, Connolly J, Jones SK et al (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 36:R167-R181
36. Arap W, Haedicke W, Bernasconi M et al (2002) Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A 99:1527-1531
37. Torchilin VP (2000) Drug targeting. Eur J Pharm Sci 11:S81-S91
38. Gerlowski LE, Jain RK (1986) Microvascular permeability of normal and neoplastic tissues. Microvasc Res 31:288-299
39. Shen Z, Wei W, Zhao YJ et al (2008) Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier. Eur J Pharm Sci 35:271-282
40. Chuang CY, Don TM, Chiu WY (2009) Synthesis of chitosan-based thermo- and pH-responsive porous nanoparticles by temperature-dependent self-assembly method and their application in drug release. J Polym Sci A Polym Chem 47:5126-5136
41. Shen ZY, Ma GH, Dobashi T et al (2008) Preparation and characterization of thermo-responsive albumin nanospheres. Int J Pharm 346:133-142
42. Lee CF, Wen CJ, Lin CL et al (2004) Morphology and temperature responsiveness-swelling relationship of poly(N-isopropylamide-chitosan) copolymers and their application to drug release. J Polym Sci A Polym Chem 42:3029-3037
43. Chuang CY, Don TM, Chiu WY (2009) Synthesis and properties of chitosan-based thermo- and pH-responsive nanoparticles and application in drug release. J Polym Sci A Polym Chem 47:2798-2810
44. Stover TC, Kim YS, Lowe TL et al (2008) Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug. Biomaterials 29:359-369
45. Bakhtiari ABS, Hsiao D, Jin GX et al (2009) An efficient method based on the photothermal effect for the release of molecules from metal nanoparticle surfaces. Angewandte Chemie - International Edition 48:4166-4169
46. Purushotham S, Chang PE, Rumpel H et al (2009) Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy. Nanotechnology 20:305101-305112
47. Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ et al (2008) Nanotechnology and aptamers: applications in drug delivery. Trends Biotechnol 26:442-449
48. Welch MJ, Hawker CJ, Wooley KL (2009) The advantages of nanoparticles for PET. J Nucl Med 50:1743-1746
49. OECD (2005) Opportunities and risks of nanotechnologies. Report in co-operation with the OECD International Futures Programme. www.oecd.org/ dataoecd/32/1/44108334.pdf
50. Barakat NS (2009) Magnetically modulated nanosystems: a unique drug-delivery platform. Nanomedicine (Lond) 4:799-812